findmyKOL
Clinical trialNCT02064881UnknownPhase 2/PHASE3Interventional

Efficacy Study of Metformin Glycinate on Postprandial Lipemia

SponsorLaboratorios Silanes S.A. de C.V.Enrollment72Type 2 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Francisco J Gómez, Doctor

    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mexico
  • Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán

    Mexico City, Mexico City, Mexico

    Francisco J Gómez, Doctor
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2015
Primary completion
30 Apr 2020
Completion
31 Aug 2020
Last update posted
30 Jan 2018
Registered enrollment
72
Registry id
NCT02064881

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.